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Abstract Producing a healthy immune system capable of
defending against pathogens, while avoiding autoimmunity,
is dependent on thymic selection. Positive selection yields
functional T cells that have the potential to recognize both
self and foreign antigens. Therefore, negative selection
exists to manage potentially self-reactive cells. Negative
selection results from the induction of anergy, receptor
editing, clonal diversion (agonist selection), and/or clonal
deletion (apoptosis) in self-reactive clones. Clonal deletion
has been inherently difficult to study because the cells of
interest are undergoing apoptosis and being eliminated
quickly. Furthermore, analysis of clonal deletion in humans
has proved even more difficult due to availability of
samples and lack of reagents. Mouse models have thus
been instrumental in achieving our current understanding of
central tolerance, and the evolution of elegant model
systems has led to an explosion of new data to be
assimilated. This review will focus on recent advances in
the field of clonal deletion with respect to three aspects: the
development of physiological model systems, signaling
pathways that lead to apoptosis, and antigen presenting cell
types involved in the induction of clonal deletion.
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The prevention of autoimmunity is primarily the outcome
of central tolerance, which is achieved when thymocytes
with high affinity for self-peptide/major histocompatibility
complex (self-p/MHC) undergo negative selection. Four
outcomes of negative selection have been described. First,
receptor editing is a process by which thymocytes with high
affinity for self-p/MHC are instructed to generate a second
rearrangement of the T cell receptors (TCR)α loci, thereby
altering the specificity of the TCR [1–4]. Secondly, anergy,
or a state of induced unresponsiveness, has also been
described [5]. The relative contribution of receptor editing
and anergy to central tolerance is thought to be minimal.
Instead, clonal diversion (agonist selection) of high-affinity
thymocytes into lineages that attain immunoregulatory
function is very important (reviewed in [6–9]). Finally,
clonal deletion (induction of apoptosis in self-reactive
clones) is the predominate mechanism by which central
tolerance is achieved and will be the focus of this review.
Model systems
In 1957, Sir Macfarlane Burnet first proposed the concept
of “repertoire purging” as a mechanism of lymphocyte
tolerance [10]. This process was first described experimen-
tally for thymocytes by studying clonal deletion in response
to superantigens [11] (see Table 1). Superantigens are
molecular remnants of proviruses in the murine genome
that cross-link particular Vβ segments of TCRs with class
II MHC. While this mimics a high-affinity TCR ligation, it
is unclear if the downstream signaling events are entirely
the same as stimulation by p/MHC. Soon after, in vitro
stimulation of thymocytes with high-affinity ligands was
utilized to model clonal deletion [12–14]. However, it is
unlikely that in vitro stimulation recapitulates the in vivo
process of clonal deletion because the intact thymic
microenvironment is missing. The switch to in vivo models
was a substantial improvement and first utilized the
injection of TCR-cross-linking antibodies to simulate
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high-affinity TCR ligation [15]. However, it was more
recently observed that activation of peripheral Tcells and their
subsequent release of pro-inflammatory cytokines and stress
hormones [16] could be obscuring TCR-induced death of DP
thymocytes. The development of TCR transgenic mice was a
major advancement in the field of thymic development and
allowed researchers to examine negative selection in
response to true p/MHC stimulation. Some studies have
utilized exogenous administration of peptide to induce
negative selection [17], but this also has the caveat of
activation of peripheral T cells [18, 19]. A more physiolog-
ical model has been to examine the response to endogenous
high-affinity peptides, either produced transgenically (neo-
self-antigens) [4, 20, 21] or naturally occurring [22, 23].
The use of different model systems has led to
conflicting conclusions about the developmental stage at
which thymocytes undergo clonal deletion. For example,
superantigen studies have suggested that deletion occurs at
the single positive (SP) stage, whereas the examination of
TCR transgenics and endogenous self-antigens have
suggested that deletion occurs at the transition from
double negative (DN) to double positive (DP). This
apparent discrepancy can be partially rectified by obser-
vation that superantigens are primarily expressed in the
medulla, which is the site where SP thymocytes reside.
Furthermore, the nature of transgenic TCR expression has
called into question the deletion observed at the DN to DP
transition. Wild type thymocytes rearrange their TCRβ
loci at the DN stage and if successful, they transition to the
DP stage and commence rearrangement of the TCRα loci.
Thus, thymocytes are not competent to undergo deletion
until they have expressed a heterodimeric TCRαβ at the
DP stage. However, TCR transgenic thymocytes express
both TCRα and TCRβ chains early at the DN stage and
probably undergo negative selection prematurely, which
could explain the observation that deletion happens at the
DN to DP transition. It is clear that the nature of TCR and
self-antigen expression can dramatically impact the timing
of clonal deletion and perhaps the molecular mechanism
by which apoptosis is induced. It is therefore important to
move forward by making use of the most physiological
tools available.
Table 1 A summary of model systems used to study negative selection
Model system Caveats Advantages Disadvantages
Superantigens Only particular Vβ TCR
are deleted
Endogenous antigen Independent of TCR affinity for p/MHC
Expression mostly in
medulla
TCR signal may be qualitatively or
quantitatively distinct
In vitro Costimulation required Technically simple Intact thymic microenvironment lacking
αCD3/αCD28
TCR Tg peptide
In vivo: αCD3/αCD28 Intact in vivo environment Activation of peripheral T cells causes
nonspecific deletion. Glucocorticoid mediated
In vivo: TCR Tg with
injected peptide
Intact in vivo environment Activation of peripheral T cells causes
nonspecific deletion. Cytokine mediated
In vivo: TCR Tg with
transgenic neo-self antigen
Intact in vivo environment Early TCR expression





In vivo: TCR Tg with
endogenous self-antigen
Intact in vivo environment Early TCR expression
TCR expression level higher than
normal on thymic precursors
High precursor frequency/monoclonal
In vivo: TCR Tg mixed bone
marrow chimeras with
endogenous self-antigen
Intact in vivo environment Early TCR expression
Precursor frequency is lower TCR expression level higher than
normal on thymic precursors
In vivo: “On-time” TCR Tg
with endogenous self-antigen
Intact in vivo environment TCR expression somewhat higher
than normal on thymic precursorsAppropriate TCR timing
(can use in mixed chimeras to
obtain low precursor frequency)
In vivo: Vβ transgenics with
endogenous self or neo-self antigens
Intact in vivo environment Inability to track cells prior to
selection in DP thymocytesAppropriate TCR timing and level
Precursor frequency is lower/oligoclonal
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As an example, our laboratory recently generated a TCR
transgenic mouse that recapitulates the appropriate timing
of TCRα expression at the DP stage (the HYcd4 model)
[24]. HYcd4 thymocytes bear the same TCR as the original
HY transgenic mouse made by Harold Von Boehmer’s
laboratory [23] and has a high affinity for a self-peptide
derived from the Y chromosome in male mice, but because
of the appropriately timed expression of the HY TCRα
chain at the DP stage, they undergo deletion at the DP to SP
transition. This is in stark contrast to when the TCRα chain
is expressed prematurely in DN thymocytes and deletion
occurs at the DN to DP transition (either in the conven-
tional HY mouse [23] or when we utilized lck-driven Cre
[24]). Other studies have utilized TCRβ-only transgenic
mice to eliminate nonphysiologic artifacts of transgenic
TCRα expression [21, 25]. This approach has the added
benefit of producing an oligoclonal repertoire with reduced
precursor frequency of antigen-specific thymocytes, which
also corrects defects in thymic architecture that are typical
of conventional TCR transgenics [26, 27]. The latter study
by Gallegos and Bevan also made use of the unique
expression of tissue-restricted antigens (TRAs) in the
medulla (explained in more detail below). This system
obviates the artifacts introduced by premature transgenic
TCR expression because only postpositive selection thy-
mocytes, transitioning from the DP to SP stage and
migrating to the medulla, are encountering high-affinity
antigen and undergoing deletion (See Fig. 1). One lingering
defect of all TCR transgenic models is the expression level
of the TCR transgenes. Wild-type DP thymocytes express
very little TCR on their cell surface and upregulate its
expression following positive selection, whereas TCR
transgenes driven off of strong promoters express at higher
levels. Unfortunately, creating a TCRα knock-in into the
endogenous locus still bears this artifact [28], although a
TCRβ knock-in has not yet been created. Thus, a model for
completely physiological transgenic TCR expression
remains elusive. Future studies examining negative selection
should strive to make use of models that have appropriately
timed TCR expression, at physiological levels, with high
affinity for a physiologically expressed, endogenous self-
antigen. Precursor frequency of antigen-specific cells should
also be minimized. Ideally, the analysis of a polyclonal
repertoire should be employed; however, it is currently
difficult to identify small numbers of precursors, due to the
fact that DP thymocytes express low levels of TCR and are
not easily distinguished by p/MHC tetramer staining.
Molecular mediators of clonal deletion
A fundamental question of T cell development has been: How
does a thymocyte distinguish between positive and negative
selection ligands? The pervasive “affinitymodel” predicts that
the kinetics of TCR binding to self-p/MHC determines this
outcome. There is much support for this model, and recently,
the precise threshold for this distinction based on affinity was
determined for class I MHC-restricted TCRs [29]. Nonethe-
less, how a cell translates TCR affinity into the decision
between life and death is less well understood. It has been
suggested that high-affinity TCR ligation induces a confor-
mational change in the cytoplasmic tail of CD3ɛ, which
exposes a polyproline sequence that serves as a binding site
for the adapter protein Nck [30]. However, another study
suggested that low-affinity interactions also expose the
polyproline sequence, albeit less efficiently [31]. Recently,
Mingueneau and colleagues created knock-in mice with a
mutation in the CD3 polyproline region. Surprisingly, they
found that binding of Nck does not depend on previous TCR
ligation. Additionally, positive selection was affected by
introduction of the mutation in two TCR transgenic models,
but negative selection was not [32]. The misshapen-Nck-
interacting kinase-related kinase (MINK) was also suggested
to be important for the induction of negative selection [33],
although this finding has not further corroborated. With
respect to TCR-proximal signaling events, it has been
suggested that differential activation of the extracellular
signal-regulated kinase (ERK) and c-Jun N-terminal kinase
(JNK) pathways is important in this discrimination (dis-
cussed in depth in [34]). A recent report extended these
findings by demonstrating the differential subcellular local-
ization of Ras and mitogen-activated protein kinase signaling
intermediates in response to positively and negatively
selecting ligands [35]. Thus, it appears that Ras-mediated
activation of the ERK pathway is dispensable for clonal
deletion. Interestingly, Ras signaling is not only involved in
positive selection of conventional T cells [36] but also in the
generation of Foxp3+ Tregs [37], which seem to be selected
by high affinity ligands [6]. This may be important for the
decision between clonal deletion and clonal diversion. It was
also recently shown that deficiency of the protein phospha-
tase G5PR resulted in hyperactivation of JNK and caspase 3
[38], indicating that G5PR inhibits apoptosis in the steady
state and that overcoming this inhibition by G5PR is perhaps
necessary for clonal deletion. A role for costimulation to
induce clonal deletion has also been suggested. However,
this has been controversial, likely due to use of different
model systems (see [34] for a thorough review). While
αCD28 strongly costimulates apoptosis in vitro, no single
costimulatory molecule has been shown to be required in all
models of clonal deletion. It is possible that multiple distinct
costimulatory molecules function redundantly in clonal
deletion.
The signals leading to clonal deletion ultimately activate
the apoptosis pathway (see [39] for a detailed review), and
a number of groups have implicated the orphan nuclear
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steroid receptor Nur77 as being necessary [40, 41]. It was
shown using cultured thymocytes that myocyte enhancer-
binding factor 2D (MEF2D) and ERK5 mediate transcription
of Nur77 [42]. On the other hand, Nur77 expression is
repressed by histone deacetylase 7 (HDAC7), and this
inhibition can be overcome by TCR stimulation that
activates protein kinase D1 which subsequently phosphor-
ylates HDAC7 and promotes its nuclear export [43–45].
While it has been well documented that Nur77 is induced
following a strong TCR stimulation, it is less clear how
Nur77 exerts its pro-apoptotic function. It was first proposed
that Nur77 acts a transcription factor to promote apoptosis
[46], but a more recent report suggested that Nur77 mediates
apoptosis by translocating to the mitochondria where it
sequesters the anti-apoptotic molecule Bcl-2 [47]. It remains
unclear if the role of Nur77 as a transcription factor is also
necessary. Defining the precise role for Nur77 in negative
selection has been further complicated by the observation
that Nor-1, a closely related family member, can have
functional redundancy with Nur77 [48].
The pro-apoptotic molecule Bim also plays a central role in
clonal deletion [49]. The precise mechanisms leading to Bim
induction have not been fully elucidated, although Ca2+ and
protein kinase C were suggested to be important [50]. A
number of recent reports have investigated the transcriptional
profile of thymocytes undergoing negative selection [51–55].
The most recent of these, by Baldwin and Hogquist,
compared the gene array data sets generated by the different
groups and found surprisingly little overlap between them.
Specifically, only Bim, Nur77, PD-1, and Gadd45β were
consistently found to be upregulated. This might suggest that
clonal deletion only requires a small number of genes to be
newly synthesized. However, it has yet to be demonstrated
that new transcription of any of these genes after the initial
TCR ligation is absolutely necessary for deletion. It has been
suggested that transcription of Bim is required [50], but it
has also been argued that phosphorylation of Bim is the
critical event in promoting clonal deletion [56].
Finally, an intriguing report recently suggested that
posttranscriptional regulation of mRNA by microRNAs might
be important in the distinction between positive and negative
selection [57]. Li et al. showed that miR1–181a acts as an
intrinsic “rheostat” to control T cell sensitivity in thymocytes
and mature T cells. It is likely that miR-181a plays a role in
Fig. 1 Distinct stages of clonal
deletion in the thymus. DP
thymocytes are positively se-
lected in the thymic cortex when
they interact with cortical thy-
mic epithelial cells (cTEC).
cTEC themselves are likely not
efficient inducers of clonal de-
letion. However, DP thymocytes
that are triggered through the
TCR upregulate CCR7. This
facilitates their movement to-
ward the thymic medulla. It may
also facilitate interaction with
dendritic cells (DC) in the cortex
(upper right box) which produce
CCR7 ligands. Cortical dendritic
cells are required for efficient




tissue-specific self antigens are
deleted later, at the SP stage in
the thymic medulla (lower right
box). Medullary thymic
epithelial cells (mTEC) produce
tissue specific self-antigens in
an AIRE dependent fashion, and
can directly present to SP
thymocytes. Dendritic cells,
which are abundant in the
medulla, can also cross present
antigens for clonal deletion
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setting the bandwidth for discrimination of positive and
negative selection signals, and perhaps the regulation of miR-
181a itself or its targets plays a role in inducing apoptosis
following a high-affinity TCR signal. Our understanding of
the role of microRNA in T cell development is in its infancy
and is likely to be even more greatly appreciated in the
future as evidenced by other recent work examining DICER
and microRNA in T cell development and function [58–60].
Cell types that mediate clonal deletion
Cortical thymic epithelial cells
Thymocytes interact with a variety of antigen-presenting
cells during the course of their development. DN thymocytes
enter the thymus at the corticomedullary junction (CMJ) and
traverse outwards towards the subcapsular region where they
undergo rearrangement of the TCRβ chain (Fig. 1). As DPs,
they migrate randomly though a dense matrix of cortical
thymic epithelial cells (cTECs), and their engagement with
p/MHC on cTECs is crucial for positive selection [61].
Whether or not cTECs are also capable of inducing
negative selection is less clearly understood. A number of
studies have concluded that cTECs are not capable of
inducing tolerance to self-antigens [62–66]. However, there
is also much data to suggest that cTECs can in fact be
tolerogenic [4, 67–75]. This apparent contradiction is likely
explained by the observation made by Goldman et al. that
studies indicating the thymic epithelium was not capable of
inducing tolerance “were done using antigens not normally
expressed by thymic epithelium and/or targets derived from
other tissues”. They then go on to suggest that cTECs are
capable of inducing tolerance to antigens expressed by
cTECs, but not to all antigens expressed in the body. In
addition, we have shown that cTECs are inefficient at
inducing apoptosis of self-reactive thymocytes but that they
are ultimately tolerogenic because they prevented the
development of mature SP thymocytes [76]. We were
unable to determine if cTECs induced anergy or clonal
diversion of these cells, but these observations may also
help reconcile the apparent contradictions in previous
studies because the induction of tolerance can occur by
mechanisms other than clonal deletion.
An intriguing study was recently reported that potentially
changes the paradigm of cTECs in positive and negative
selection [77]. In addition to the “standard” proteasome and
the “immunoproteasome”, Murata et al. described a novel
proteasomal subunit expressed exclusively in cTECs, which
they termed β5t. This “thymoproteasome” has unique
peptidase activity with reduced chymotrypsin-like activity,
which is important for generating peptides with hydrophobic
C-termini. Hydrophobic C-termini anchor peptides in the
groove of class I MHC. Therefore, it is likely that cTECs not
only generate a unique peptide repertoire but also present
unstable class I MHC on their cell surface. These observa-
tions may explain why cTECs are critical for positive
selection, and in fact, β5t-deficient mice had a dramatic
defect in generation of CD8 SPs. This unique feature of
cTECs also potentially explains why cTECs are incapable of
inducing tolerance to antigens expressed throughout the
body and their poor ability to induce clonal deletion. It is
interesting to speculate that a similar mechanism exists in
cTECs for the generation of class II p/mHC complexes,
perhaps via cathepsins [78, 79].
Trafficking to the medulla
The notion that cTECs are not sufficient for induction of
clonal deletion is bolstered by the observation that
trafficking to the medulla is necessary for achieving
complete tolerance [80, 81] and that this migration is
primarily mediated by CCR7-dependant signaling [82, 83]
(See Fig. 1). Indeed, mice with medullar defects also display
autoimmune phenotypes (reviewed in [84]). It is commonly
believed that the medulla is a specialized anatomical
location for clonal deletion due to the high density of
dendritic cells (DC) and the peculiar ability of medullary
thymic epithelial cells (mTECs) to ectopically express
TRAs (both of which are described in further detail below).
However, a defect in clonal deletion may not be sufficient
to explain the lack of tolerance in previously mentioned
studies. This is because the medulla has also been
implicated to be important for the generation of immuno-
regulatory T cells [85–88] and for conventional T cells to
undergo final maturation and adjustment of their TCR
sensitivity to self-antigens (a process referred to as “TCR
tuning”) [89]. In addition, Reinhold Förster’s laboratory
also questioned whether or not CCR7 was the only
chemokine receptor involved in corticomedullar migration
[90]. While there is clearly medullar dysplasia in CCR7-
deficient mice and reduced medullar volume, they showed
that proportionally normal numbers of CD4 SP thymocytes
were found in the small pockets of medulla that remained.
They concluded that a redundant mechanism exists for
migration to the medulla. Importantly though, it should be
noted that the majority of SPs in the medulla were CD4
SPs, and it was impossible to distinguish if these were truly
developing thymocytes or another lineage of CD4+ T cells,
such as Foxp3+ Tregs that also reside in the medulla [91]
and may have an alternate homing mechanism.
Medullary thymic epithelial cells
Despite the complicating factors of Treg development, TCR
tuning, and the role of CCR7-mediated chemotaxis, it is clear
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that developing thymocytes must gain access to the medulla
to be screened against a panel of self-antigens uniquely
expressed there (See Fig. 1). It has been shown that
medullary thymic epithelial cells are capable of expressing
the autoimmune regulator (AIRE), which leads to the
ectopic expression of tissue-restricted antigens [92, 93].
This phenomenon of mTECs is crucial for the establish-
ment of central tolerance as AIRE-deficient humans and
mice both develop autoimmunity [94]. It has been shown
that mTECs express the costimulatory molecules B7-1 and
B7-2 and that direct presentation of TRAs by mTECs is
sufficient to induce clonal deletion of antigen-specific
thymocytes, although cross-presentation by dendritic cells
also occurs [21] (discussed in further detail below).
The development of mTECs is dependent upon a
population of CD4+ CD3− lymphoid tissue inducer cells
and receptor activator of nuclear factor κB (RANK)–
RANK ligand interactions, and their maintenance is, in part,
controlled by CD40–CD40L signaling and lymphotoxin-β
receptor (LTβR; see Fig. 1) [95–97]. Furthermore, tumor
necrosis factor receptor-associated factor 6 (TRAF6), which
signals downstream of RANK and CD40, is also needed for
mTEC development [86]. TRAF6 activates the transcription
factor NF-κB, which is also required for mTEC develop-
ment [98], as is the NF-κB-inducing kinase [85] and IκB
kinase α [99].
Recent work has also demonstrated that mTECs are a
highly dynamic population with high proliferative capacity
and a turnover rate of about 2 weeks [100, 101]. It was
observed that the majority of proliferating mTECs were
mature, UEA-1+ MHC class IIhi, and that these mature
mTECs are the ones expressing AIRE [102]. In addition, it
appears that AIRE-expressing mTECs are short-lived with
rapid turnover [103]. While AIRE-dependent TRAs are
found clustered throughout the genome, implying a role for
epigenetics in AIRE function [104], it has also been shown
that individual mTECs express a stochastic battery of
TRAs, such that each mTEC is unique with respect to its
antigen-presentation profile [105, 106]. Taken together,
these data paint a picture where mTECs are critical for the
elimination of self-reactive thymocytes and that individual
AIRE-expressing mTECs are highly diverse and turning
over rapidly. As loss of tolerance to just one tissue-
restricted antigen is sufficient to cause autoimmunity
[107], it becomes clear that thymocytes must have ample
opportunity to peruse the entire milieu of the medulla to be
adequately screened for self-reactivity. We recently showed
that the length of time that an SP thymocyte spends in the
medulla is roughly 4–5 days [108], during which a
thymocyte “tunes” its TCR and becomes refractory to
apoptosis. Therefore, a short medullary residency time of
SP thymocytes, in combination with the diversity and
turnover of mTECs expressing TRAs, may be a weak point
in the mechanism of central tolerance. Evolution has
obviously created a system that prevents overt autoimmu-
nity but bear in mind that T cell-driven autoimmunity is
disturbingly common in the human population. Finally, the
precise mechanism by which AIRE operates is not entirely
understood. AIRE most likely operates as a transcription
factor, but as mentioned above with regards to epigenetics, it
remains possible that AIRE promotes ectopic expression of
TRAs by another mechanism(s) [109]. In addition, not all
TRAs are AIRE-dependent [104]; thus, another mechanism
or molecule, similar to AIRE, must also exist, perhaps
involving LTβR [110].
Dendritic cells
Dogma states that TCR activation and clonal deletion are
most efficiently induced by bone marrow-derived cells, and
it is widely believed that dendritic cells are the principle
mediator of clonal deletion. This is because DC are thought
of as “professional” antigen presenting cells with high
levels of class II MHC on the cell surface as well as high
levels of costimulatory molecules, such as B7-1 and B7-2.
Indeed, a direct role for DC in clonal deletion has been
demonstrated [21, 111, 112]. However, the heterogeneity in
thymic DC is largely underappreciated and not completely
understood. It is unclear if all DC in the thymus are equal in
their capacity to induce clonal deletion. Work by Donskoy
and Goldschneider has shown that at least two distinct
populations of thymic DCs exist: one that develops intra-
thymically and one that is derived from peripheral DCs
migrating to the thymus [113]. It was suggested that these
two populations might have functional differences in their
ability to induce deletion of self-reactive thymocytes vs.
clonal diversion of immunoregulatory cells. Goldschneider
and Cone propose a model where intrathymically derived
DC mediate clonal deletion, whereas extrathymically
derived cells support the agonist selection of regulatory
T cells (see [114] for a comprehensive review of this
argument). It is important to note that the phenotype is
unknown of the subset of peripheral DCs that are capable of
migrating to the thymus and mediating this selection. In
line with this hypothesis, it has been shown in the human
thymus that a group of mTECs called Hassall’s corpuscles
produces TSLP (thymic stromal lymphopoietin) and this
allows DC to induce the proliferation and differentiation of
Foxp3+ Tregs [115]. Conversely, it was more recently
demonstrated that antigen-loaded, splenic DC were capable
of homing to the thymus and inducing deletion of antigen-
specific thymocytes [116]. More detailed analysis of the
phenotype of the DC migrating to the thymus was also
performed, and these DC included all subsets of splenic DC
that were present at the time of injection, although LPS-
matured DC showed a reduced capacity to home to the
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thymus. It may be that the ability of peripheral DC to
migrate to the thymus and induce deletion vs. agonist
selection might not be mutually exclusive and may depend
upon the specific environmental and experimental conditions.
It is also possible that different subsets of peripheral DC are
capable of mediating the different selection outcomes.
As potential support for the latter hypothesis, Ken
Shortman’s laboratory has shown that, in addition to
intrathymically- and extrathymically derived DCs, at least
three other DC subsets can be identified based upon cell
surface markers (reviewed in [117]). Their data showed an
initial division of DC into two populations, 35% of which
are plasmacytoid DC (pDC) and the remaining 65% are
conventional DC (cDC). The distinction between these two
populations is based on expression of CD11c and
CD45RA, with pDC being CD11cint and CD45RA+, and
cDC being CD11chi and CD45RA−. The majority of pDC
are Ly6c+, although a small fraction of Ly6c− can also be
found. Similar to pDC in the spleen and lymph node, some
thymic pDC can express CD4 and/or CD8α, but unlike
peripheral pDC, they express high levels of TLR7 and 9,
but only low levels of TLR 2, 3, and 4. Also similar to
peripheral pDC, thymic pDC express low levels of MHC
class II and costimulatory molecules and can take up
antigen by endocytosis but not phagocytosis. Thus, pDC
are weak stimulators of T cells. On the other hand, all
conventional DC are MHC class II+ and the majority are
CD8αα+. Similar to the minority population of CD8+ DC
in the spleen and lymph node, this population in the thymus
is DEC-205+ (CD205) and CD11b−. However, unlike
peripheral CD8α+ DC, some thymic CD8α+ cDC also
express BP-1, although no functional difference has yet
been shown based upon this distinction. Conventional DC
can be further subdivided by their expression of CD8α and
Sirpα (CD172a). CD8αlo Sirpα+ DCs account for 20% of
the thymic cDC population, and similar to splenic CD8α−
DC, this population is also CD11bint. While thymic cDC
express the costimulatory molecules B7-1 and B7-2 at
slightly higher levels than their peripheral counterparts, for
the most part, they appear to be immature because they are
capable of phagocytic or endocytic uptake of antigens and
process and present them on MHC class II. In addition, they
upregulate expression of MHC class II and costimulatory
molecules following activation. It is not entirely clear how
this classification of thymic DC aligns with the division
created by the Goldschneider laboratory as to the origin of
these cell types. It seems that most of CD8α+ cDC develop
intrathymically from a lymphoid prothymocyte precursor,
whereas extrathymically derived DC include the CD8α−
DC population, likely of myeloid origin.
Finally, it is well documented that the majority of thymic
DCs are found in the medulla, and therefore, it is thought
that the anatomical location of clonal deletion is at the CMJ
or in the medulla. However, we and others have noted the
sparse but distinct presence of DC in the cortex of
the thymus (See Fig. 1). This often-overlooked observation
raises the possibility that cortical DC may be sufficient to
mediate clonal deletion. Indeed, we have recently shown
that clonal deletion to ubiquitous self-antigens can occur in
the cortex, with no involvement of the medulla [76].
Furthermore, we found that thymocytes undergoing this
process were preferentially in contact with DC present in
the cortex and that conditional ablation of DC significantly
impaired clonal deletion of antigen-specific cells. The fact
that clonal deletion to ubiquitous self-antigens can occur in
the cortex does not preclude the requirement of migration to
the medulla and clonal deletion to TRAs. It does, however,
expand our thinking as to the mechanism underlying clonal
deletion. It is unknown if any phenotypic differences exist
between cortical and medullar DC, or if any subset(s) of
DC discussed previously reside preferentially in the cortex
or the medulla. It was recently shown that most cortical DC
are found in close association with small blood capillaries
that express CCR7 ligands ([118] and our unpublished
data). As positively selected thymocytes also express
CCR7, it is interesting to speculate that this exists as an
initial mechanism for screening thymocytes for clonal
deletion. It also raises the possibility that thymocyte
migration to the medulla does not occur randomly but that
CCR7+ cells travel along blood capillaries, which ulti-
mately lead to the CMJ. Finally, given that cTEC are not
efficient at inducing clonal deletion and DC are, it is likely
that a second signal that can be delivered by a DC but not a
cTEC is necessary to induce apoptosis. We have observed
that cortical DCs express B7-2, and it is tempting to think
that this is the second signal. However, as discussed
previously, there is no absolute role for costimulation by
B7-2, although it has been shown that complete deletion of
superantigen-reactive cells requires B7-1/2 and CD28
interaction [119]. Therefore, it remains possible that B7-1
and B7-2 play a role in clonal deletion, but it is probable
that other costimulatory molecules also exist.
In conclusion, recent advancements have allowed
researchers to gain a deeper understanding of the process
of clonal deletion. We are finally beginning to understand
the molecular pathways that are necessary for the elimina-
tion of self-reactive thymocytes, as well as the cellular
players that contribute to this process. As the field moves
ahead, it is important to develop and use the most
physiological tools possible and to consider the intricate
anatomical microenvironments of the thymus in order to
gain a clear understanding of clonal deletion.
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